These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16918195)

  • 1. Hunter syndrome: case report and review of literature.
    Ogunbiyi A; Adeyinka AO; Ogah SO; Baiyeroju AM
    West Afr J Med; 2006; 25(2):169-72. PubMed ID: 16918195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hunter syndrome with late age of presentation: clinical description of a case and review of the literature.
    Gupta A; Uttarilli A; Dalal A; Girisha KM
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hunter syndrome follow-up after 1 year of enzyme-replacement therapy.
    Puiu M; Chirita-Emandi A; Dumitriu S; Arghirescu S
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23307460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin eruption as the presenting sign of Hunter syndrome IIB.
    Demitsu T; Kakurai M; Okubo Y; Shibayama C; Kikuchi Y; Mori Y; Sukegawa K; Mizuguchi M
    Clin Exp Dermatol; 1999 May; 24(3):179-82. PubMed ID: 10354174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidosis type II: skeletal-muscle system involvement.
    Morini SR; Steiner CE; Gerson LB
    J Pediatr Orthop B; 2010 Jul; 19(4):313-7. PubMed ID: 20354449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative structural studies of urinary glycosaminoglycans in the Hurler and Hunter syndromes.
    Ramage P; Cunningham WL
    Biochim Biophys Acta; 1975 Dec; 411(2):325-33. PubMed ID: 127616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
    Martin R; Beck M; Eng C; Giugliani R; Harmatz P; Muñoz V; Muenzer J
    Pediatrics; 2008 Feb; 121(2):e377-86. PubMed ID: 18245410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
    Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
    Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of Hunter syndrome using fetal plasma.
    Lissens W; Van Lierde M; Decaluwe J; Foulon W; Evrard P; Van Hoof F; Freund M; Liebaers I
    Prenat Diagn; 1988 Jan; 8(1):59-62. PubMed ID: 3125535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucopolysaccharidosis type II, Hunter's syndrome.
    Tylki-Szymańska A
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():107-13. PubMed ID: 25345092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved assay for iduronate 2-sulphate sulphatase in serum and its use in the detection of carriers of the Hunter syndrome.
    Archer IM; Harper PS; Wusteman FS
    Clin Chim Acta; 1981 Apr; 112(1):107-12. PubMed ID: 6786801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester diagnosis of Hunter syndrome: very low iduronate sulphatase activity in chorionic villi from a heterozygous female fetus.
    Cooper A; Thornley M; Wraith JE
    Prenat Diagn; 1991 Sep; 11(9):731-5. PubMed ID: 1820774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging findings in Hunter syndrome.
    Finn CT; Vedolin L; Schwartz IV; Giugliani R; Haws CA; Prescot AP; Renshaw PF
    Acta Paediatr; 2008 Apr; 97(457):61-8. PubMed ID: 18339191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucopolysaccharidosis type II with inguinal hernia.
    Rayamajhi A; Pokharel PJ; Chapagain R; Rayamajhi AK
    J Nepal Health Res Counc; 2013 Sep; 11(25):293-5. PubMed ID: 24908534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of children with Hunter syndrome - a case study.
    Little C; Gould R; Hendriksz C
    Br J Nurs; 2009 Mar 12-25; 18(5):321-2. PubMed ID: 19273994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II--Hunter syndrome).
    Wraith JE; Cooper A; Thornley M; Wilson PJ; Nelson PV; Morris CP; Hopwood JJ
    Hum Genet; 1991 Jun; 87(2):205-6. PubMed ID: 1906048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome.
    Wilson PJ; Suthers GK; Callen DF; Baker E; Nelson PV; Cooper A; Wraith JE; Sutherland GR; Morris CP; Hopwood JJ
    Hum Genet; 1991 Mar; 86(5):505-8. PubMed ID: 1901826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new polymorphism in the iduronate-2-sulphatase gene. Implications for the diagnosis of Hunter disease.
    Gort L; Chabás A; Coll MJ
    J Inherit Metab Dis; 1999 Oct; 22(7):844. PubMed ID: 10518288
    [No Abstract]   [Full Text] [Related]  

  • 19. Mucopolysaccharidosis type II in females: case report and review of literature.
    Tuschl K; Gal A; Paschke E; Kircher S; Bodamer OA
    Pediatr Neurol; 2005 Apr; 32(4):270-2. PubMed ID: 15797184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of Hunter syndrome.
    Archer IM; Kingston HM; Harper PS
    Prenat Diagn; 1984; 4(3):195-200. PubMed ID: 6431402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.